-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Upgrades Afya to Buy, Lowers Price Target to $19

Benzinga·09/08/2025 10:38:16
Listen to the news
UBS analyst Andre Salles upgrades Afya (NASDAQ:AFYA) from Neutral to Buy and lowers the price target from $19.5 to $19.